Here, we report a phenotypic and mechanistic determination that MEIS proteins promote indolent and non-metastatic prostate cancer via the HOXB13-dependent regulation of extracellular proteoglycans, in particular the multi-RTK inhibitor Decorin. The gene discussed is DCN; the disease is prostate carcinoma.